Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Pharma Notes Boost from Generic Cold Drug

publication date: Feb 25, 2008

China Pharma Holdings, Inc. is touting the revenues it receives from Pusen OK, a generic version of cold medication Aleve-D™. The company said Pusen OK contributed $4.1 million in revenues in 2007, and it has received another $5.6 million in orders this early in 2008 from a single distributor. The recent heavy winter weather in China has helped sales, according to China Pharma. Pusen OK is the only generic form of Aleve-D™ available in China. The company says it provides relief from cold and flu symptoms without causing drowsiness. More details...

Stock Symbol: (OTCBB: CPHI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here